Whitepaper: Literature mining in support of drug discovery

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

The drug discovery enterprise provides strong drivers for data integration.While attention in this arena has tended to focus on integration of primary data from omics and other large platform technologies contributing to drug discovery and development, the scientific literature remains a major source of information valuable to pharmaceutical enterprises, and therefore tools for mining such data and integrating it with other sources are of vital interest and economic impact.

Pankaj Agarwal, Director, Systematic Drug Repositioning, Computational Biology, GlaxoSmithKline kindly provided this whitepaper that provides a brief overview of approaches to literaturemining as they relate to drug discovery, and offers an illustrative case study of a ‘lightweight’ approach we have implemented within an industrial context.

Download the whitepaper here for more information